Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|July 4, 1998
Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methodsC Bouchet, F Spyratos, K Hacène, et al.
Biology of the Cell|January 1, 1989
Cytokeratin analysis of breast and leukemia tumor cell lines by flow cytometryM Ferrero, F Spyratos, A Desplaces, et al.
Presse Medicale (Paris, France : 1983)|June 15, 1991
[Optimal sampling for diagnostic and prognostic purposes before first-line chemotherapy of breast cancer]M Tubiana-Hulin, M Briffod, F Spyratos, et al.
Cancer Research|November 1, 1993
Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastasesZ Bouizar, F Spyratos, S Deytieux, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1986
Tissue glycolytic enzymes in primary breast cancer patients receiving adjuvant chemotherapyF Spyratos, J Oglobine, R Lidereau, et al.
Bulletin De L'Academie Nationale De Medecine|March 1, 1994
[Difficulties encountered in the evaluation of prognostic criteria of breast cancer: apropos of the experience of the René Huguenin center]F Spyratos, V Le Doussal, M Tubiana-Hulin, et al.
Breast Cancer Research and Treatment|January 1, 1996
Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissuesC Bouchet-Bernet, F Spyratos, C Andrieu, et al.
Bulletin Du Cancer|September 1, 1994
[Prognostic value of urokinase-type plasminogen activator and 2 inhibitors PAI-1 and PAI-2 in breast cancer]C Bouchet, F Spyratos, P M Martin, et al.
British Journal of Cancer|February 1, 1994
Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomasC Bouchet, F Spyratos, P M Martin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Technical evaluation of thymidine kinase assay in cytosols from breast cancers. EORTC Receptor Study Group ReportS Romain, F Spyratos, O Guirou, et al.
Pageof 9